The nigrostriatal DA pathway and Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of neural transmission. Supplementum

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-211-45295-0_13PMID 17017512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flotillin-1 in the substantia Nigra of the Parkinson brain and a predominant localization in catecholaminergic nerves in the rat brain

  2009cited by this paper
• Receptor-receptor interactions as an integrative mechanism in nerve cells

  2007cited by this paper
• Role of electrostatic interaction in receptor-receptor heteromerization

  2007cited by this paper
• Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.

  2007cited by this paper
• Nuclear parcellation of certain immunohistochemically identifiable neuronal systems in the midbrain and pons of the Highveld molerat (Cryptomys hottentotus).

  2006cited by this paper
• Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.

  2006cited by this paper
• Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: relevance for volume transmission.

  2006cited by this paper
• Establishing order at the systems level in mammalian brain evolution.

  2005cited by this paper
• Involvement of Chloride in Apoptotic Cell Death Induced by Activation of ATP-sensitive P2X7 Purinoceptor*

  2005cited by this paper
• Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes

  2005cited by this paper
• Sensory transduction of pulmonary reactive oxygen species by capsaicin‐sensitive vagal lung afferent fibres in rats

  2005cited by this paper
• Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for l-dopa induced dyskinesias

  2005cited by this paper
• How receptor mosaics decode transmitter signals. Possible relevance of cooperativity.

  2005cited by this paper
• Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion

  2004cited by this paper
• Stages in the development of Parkinson’s disease-related pathology

  2004cited by this paper
• The Distribution and Morphological Characteristics of Catecholaminergic Cells in the Diencephalon and Midbrain of the Bottlenose Dolphin (Tursiops truncatus)

  2004cited by this paper
• Free radicals and aging.

  2004cited by this paper
• CHAPTER 18 – Basal Ganglia

  2004cited by this paper
• Striatal plasticity and extrapyramidal motor dysfunction.

  2004influential reference
• Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection.

  2004cited by this paper
• Toward linking structure with function in ATP-sensitive K+ channels.

  2004cited by this paper
• Cellular distribution and functions of P2 receptor subtypes in different systems.

  2004cited by this paper
• Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors.

  2004cited by this paper
• Agonists and antagonists acting at P2X7 receptor.

  2004cited by this paper
• Energy gradients for the homeostatic control of brain ECF composition and for VT signal migration: introduction of the tide hypothesis

  2004cited by this paper
• Receptor heteromerization in adenosine A2A receptor signaling

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia.

  2003cited by this paper
• Oligomerization of adenosine A2A and dopamine D2 receptors in living cells.

  2003cited by this paper
• Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

  2003cited by this paper
• Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons

  2003cited by this paper
• Activation of ATP-sensitive K+ (KATP) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release

  2003cited by this paper
• Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

  2003cited by this paper
• Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum

  2002cited by this paper
• Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.

  2002cited by this paper
• Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors*

  2002cited by this paper
• Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor.

  2002cited by this paper
• The neuronal environment : brain homeostasis in health and disease

  2002cited by this paper
• Molecular physiology of P2X receptors.

  2002cited by this paper
• Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems

  2002cited by this paper
• Evidence for environmental causation of Parkinson's disease.

  2002cited by this paper
• Transmitter-Receptor Mismatches in Central Dopamine, Serotonin, and Neuropeptide Systems: Further Evidence for Volume Transmission

  2001cited by this paper
• Heterodimerization of G-protein-coupled receptors in the CNS.

  2001cited by this paper
• Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.

  2001cited by this paper
• ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction.

  2001cited by this paper
• Involvement of the direct striatonigral pathway in levodopa‐induced sensitization in 6‐hydroxydopamine‐lesioned rats

  2000cited by this paper
• Energetics in the pathogenesis of neurodegenerative diseases.

  2000cited by this paper
• ATP: an extracellular signaling molecule between neurons and glia.

  2000cited by this paper
• Intracerebral infusion of 3H‐dopamine and 3H‐mannitol in the striatum of halothane‐anaesthetized male rats.A dual‐probe microdialysis study of long‐distance diffusion

  2000cited by this paper
• Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes.

  2000cited by this paper
• Dopamine D4 receptors.

  2000cited by this paper
• Adenosine receptors and Parkinson's disease

  1999cited by this paper
• Brain Uncoupling Protein 2: Uncoupled Neuronal Mitochondria Predict Thermal Synapses in Homeostatic Centers

  1999cited by this paper
• On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.

  1999cited by this paper
• Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia.

  1998cited by this paper
• Neurogenic control of the cerebral microcirculation: is dopamine minding the store?

  1998cited by this paper
• Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

  1998cited by this paper
• Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain.

  1996cited by this paper
• The concept of trophic units in the central nervous system

  1995cited by this paper
• Free radicals and aging

  1994cited by this paper
• Serotonin, the cerebellum, and ataxia

  1993cited by this paper
• MONITORING MOLECULES IN NEUROSCIENCE

  1991cited by this paper
• Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

  1991cited by this paper
• Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.

  1988cited by this paper
• Dopaminergic Systems in the Brain and Pituitary

  1985cited by this paper
• The Dopaminergic System

  1985cited by this paper
• The Rat nervous system

  1985cited by this paper
• Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects.

  1984cited by this paper
• New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram.

  1982cited by this paper
• Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites.

  1981cited by this paper
• Aspects on receptor regulation and isoreceptor identification.

  1980cited by this paper
• The mesolimbic dopamine system: evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population.

  1980cited by this paper
• Quantitative data on serotonin nerve terminals in adult rat neocortex.

  1976cited by this paper
• Serotonin nerve terminals in adult rat neocortex.

  1975cited by this paper
• Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

  1975cited by this paper
• Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

  1974cited by this paper
• Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats.

  1972cited by this paper
• Mapping of central monoamine neurons in the monkey

  1972cited by this paper
• The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptake.

  1972cited by this paper
• Amphetamines and related compounds : E. Costa and S. Garattini (Editors.) (Raven Press, New York, 1970, 962 p. $ 28.50)

  1971cited by this paper
• Evidence for the existence of monoamine neurons in the central nervous system

  1965cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

  1965cited by this paper
• FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT.

  1965cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. 3. THE MONOAMINE NERVE TERMINAL.

  1965cited by this paper
• STUDIES ON ADRENERGIC NERVES. THE USE OF RAT AND MOUSE IRIS FOR DIRECT OBSERVATIONS ON THEIR PHYSIOLOGY AND PHARMACOLOGY AT CELLULAR AND SUBCELLULAR LEVELS.

  1965cited by this paper
• A METHOD FOR THE DEMONSTRATION OF MONOAMINE-CONTAINING NERVE FIBRES IN THE CENTRAL NERVOUS SYSTEM.

  1964cited by this paper
• DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

  1964cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

  1964cited by this paper
• Cellular localization of brain monoamines.

  1962cited by this paper

• Speech Motor Deficits in Developmental Stuttering and Parkinson's Disease: From Cellular and Circuit to Network‐Level Disruptions

  2026cites this paper
• PF-06447475 Molecule Attenuates the Neuropathology of Familial Alzheimer’s and Coexistent Parkinson’s Disease Markers in PSEN1 I416T Dopaminergic-like Neurons

  2025cites this paper
• Manejo clínico y quirúrgico de los feocromocitomas y paragangliomas

  2025cites this paper
• Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in Parkinson's disease model mice.

  2022cites this paper
• What happens in the top athletes mind? a review study

  2021cites this paper
• P2X7 receptor/NLRP3 inflammasome complex and α‐synuclein in peripheral blood mononuclear cells: a prospective study in neo‐diagnosed, treatment‐naïve Parkinson’s disease

  2021cites this paper
• Neurotransmitters, Cell Types, and Circuit Mechanisms of Motor Skill Learning and Clinical Applications

  2021cites this paper
• Plant natural products as source of new P2 receptors ligands.

  2020cites this paper
• Parkinson’s Disease: An Overview of Various Treatments

  2020cites this paper
• Oleh Hornykiewicz: A Giant who Transformed Neuroscience over a 70-Year Career

  2020cites this paper
• Brilliant Blue G, but not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease

  2017cites this paper
• Optimisation of murine organotypic slice culture preparation for a novel sagittal-frontal co-culture system.

  2017cites this paper
• Dopamine receptor D2 is correlated with gastric cancer prognosis

  2017cites this paper
• Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex

  2017cites this paper
• Investigating The Acute Levodopa Response In Early To Advanced Parkinson’s Disease

  2017cites this paper
• Neuronal vs Glial Cell Contribution to Adenosine A2A Receptor-Induced Neurodegeneration

  2017cites this paper
• Highly Sensitive Dopamine Detection Using a Bespoke Functionalised Carbon Nanotube Microelectrode array

  2017cites this paper
• Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism

  2017cites this paper
• Purinergic signaling in Parkinson's disease. Relevance for treatment.

  2016cites this paper
• Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats.

  2016cites this paper
• Microelectrode array fabrication for electrochemical detection with carbon nanotubes.

  2016cites this paper
• Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease

  2016cites this paper
• The Role of Coffee in the Therapy of Parkinson's Disease

  2015cites this paper
• Altered Decision Behavior of Dopamine Receptor Knock-out Mice in a Free Binary Choice Task

  2015cites this paper
• Modulation of the expression and function of dopaminergic presynaptic proteins by the statins : Potential implication for the therapeutic intervention in Parkinson’s disease.

  2015cites this paper
• Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System

  2015cites this paper
• Dynamic Re-wiring of Neural Circuits in the Motor Cortex in Mouse Models of Parkinson's Disease

  2015cites this paper
• Altered Decision Behavior of Dopamine Receptor Knock-out Mice in a Free Binary Choice Task

  2014cites this paper
• Drug‐Target Residence Time—A Case for G Protein‐Coupled Receptors

  2014cites this paper
• Characterization of the interaction of the dopamine D2 receptor and the cannabinoid CB1 receptor and its effects on signal transduction pathways

  2013cites this paper
• Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

  2013cites this paper
• Genetic dissection of the behavioral effects of the dopamine receptor agonist SKF83959 does not support the D1/D2 receptor heteromer model

  2013cites this paper
• Neuroprotective role of fibronectin in neuron-glial extrasynaptic transmission☆

  2013cites this paper
• Dopamine in the Immune System: Dopamine Receptors in Immune Cells, Potent Effects, Endogenous Production and Involvement in Immune and Neuropsychiatric Diseases

  2012cites this paper
• Many mouths to feed: the control of food intake during lactation.

  2012cites this paper
• The Hydrolysis of Striatal Adenine- and Guanine-Based Purines in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease

  2011cites this paper
• Dopaminergic Projections from Midbrain to Primary Motor Cortex Mediate Motor Skill Learning

  2011cites this paper
• New insights into the altered fibronectin matrix and extrasynaptic transmission in the aging brain

  2011cites this paper
• On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7 receptor antagonist A-438079

  2010cites this paper
• Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice.

  2010cites this paper
• The discovery of central monoamine neurons gave volume transmission to the wired brain.

  2010cites this paper
• The chemical synthesis, pharmaceutical preparation and toxicity analysis of fluorodopa for positron emission tomography (PET) brain imaging in South Africa

  2010cites this paper
• From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.

  2010cites this paper
• Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.

  2010cites this paper
• Behavioural sensitisation during dopamine replacement therapy in Parkinson's disease is reminiscent of the addicted brain.

  2009cites this paper
• Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers

  2009cites this paper
• Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brain of the rock hyrax, Procavia capensis.

  2009cites this paper
• Author ' s personal copy INTERMITTENT DOPAMINERGIC STIMULATION CAUSES BEHAVIORAL SENSITIZATION IN THE ADDICTED BRAIN AND PARKINSONISM

  2009cites this paper
• Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brain of the Cape porcupine (Hystrix africaeaustralis): increased brain size does not lead to increased organizational complexity.

  2008cites this paper
• On the key role played by altered protein conformation in Parkinson’s disease

  2008cites this paper
• What is reinforced by phasic dopamine signals?

  2008cites this paper
• From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission.

  2007cites this paper
• Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease

  2007cites this paper
• Dopamine D4 receptor activation decreases the expression of μ‐opioid receptors in the rat striatum

  2007cites this paper
• Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides.

  2007cites this paper
• Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease.

  2007cites this paper
• Intramembrane receptor–receptor interactions: a novel principle in molecular medicine

  2006cites this paper
• Provided for Non-commercial Research and Educational Use Only. Not for Reproduction, Distribution or Commercial Use

  year unknowncites this paper